<?xml version='1.0' encoding='utf-8'?>
<document id="18447664"><sentence text="Nonbloody, red stools from coadministration of cefdinir and iron-supplemented infant formulas."><entity charOffset="47-55" id="DDI-PubMed.18447664.s1.e0" text="cefdinir" /><entity charOffset="60-64" id="DDI-PubMed.18447664.s1.e1" text="iron" /><pair ddi="false" e1="DDI-PubMed.18447664.s1.e0" e2="DDI-PubMed.18447664.s1.e0" /><pair ddi="false" e1="DDI-PubMed.18447664.s1.e0" e2="DDI-PubMed.18447664.s1.e1" /></sentence><sentence text="Cefdinir is an extended-spectrum, third-generation cephalosporin that may be used for treatment of acute otitis media in patients allergic to penicillin"><entity charOffset="0-8" id="DDI-PubMed.18447664.s2.e0" text="Cefdinir" /><entity charOffset="51-64" id="DDI-PubMed.18447664.s2.e1" text="cephalosporin" /><entity charOffset="142-152" id="DDI-PubMed.18447664.s2.e2" text="penicillin" /><pair ddi="false" e1="DDI-PubMed.18447664.s2.e0" e2="DDI-PubMed.18447664.s2.e0" /><pair ddi="false" e1="DDI-PubMed.18447664.s2.e0" e2="DDI-PubMed.18447664.s2.e1" /><pair ddi="false" e1="DDI-PubMed.18447664.s2.e0" e2="DDI-PubMed.18447664.s2.e2" /><pair ddi="false" e1="DDI-PubMed.18447664.s2.e1" e2="DDI-PubMed.18447664.s2.e1" /><pair ddi="false" e1="DDI-PubMed.18447664.s2.e1" e2="DDI-PubMed.18447664.s2.e2" /></sentence><sentence text=" When administered with iron-containing products, including infant formulas, cefdinir or one of its metabolites may bind to ferric ions, forming a nonabsorbable complex that imparts a reddish color to the stool"><entity charOffset="24-28" id="DDI-PubMed.18447664.s3.e0" text="iron" /><entity charOffset="77-85" id="DDI-PubMed.18447664.s3.e1" text="cefdinir" /><entity charOffset="124-135" id="DDI-PubMed.18447664.s3.e2" text="ferric ions" /><pair ddi="false" e1="DDI-PubMed.18447664.s3.e0" e2="DDI-PubMed.18447664.s3.e0" /><pair ddi="false" e1="DDI-PubMed.18447664.s3.e0" e2="DDI-PubMed.18447664.s3.e1" /><pair ddi="false" e1="DDI-PubMed.18447664.s3.e0" e2="DDI-PubMed.18447664.s3.e2" /><pair ddi="false" e1="DDI-PubMed.18447664.s3.e1" e2="DDI-PubMed.18447664.s3.e1" /><pair ddi="false" e1="DDI-PubMed.18447664.s3.e1" e2="DDI-PubMed.18447664.s3.e2" /></sentence><sentence text=" We describe a 9-month-old infant with failure to thrive and acute otitis media who developed an erythematous maculopapular rash during treatment with amoxicillin-clavulanate"><entity charOffset="151-162" id="DDI-PubMed.18447664.s4.e0" text="amoxicillin" /><entity charOffset="163-174" id="DDI-PubMed.18447664.s4.e1" text="clavulanate" /><pair ddi="false" e1="DDI-PubMed.18447664.s4.e0" e2="DDI-PubMed.18447664.s4.e0" /><pair ddi="false" e1="DDI-PubMed.18447664.s4.e0" e2="DDI-PubMed.18447664.s4.e1" /></sentence><sentence text=" His antibiotic therapy was changed to cefdinir"><entity charOffset="39-47" id="DDI-PubMed.18447664.s5.e0" text="cefdinir" /></sentence><sentence text=" Five days into a 10-day course of therapy, the infant's mother brought him to the pediatric clinic and reported the appearance of red stools" /><sentence text=" He had no associated gastrointestinal symptoms (vomiting, abdominal pain, or diarrhea)" /><sentence text=" His hematocrit and hemoglobin level were normal, and Clostridium difficile antigen studies and tests for species of Shigella, Salmonella, and Camphylobacter as well as ova and parasites were all negative" /><sentence text=" Cefdinir was discontinued, and his stools returned to normal within 48 hours"><entity charOffset="1-9" id="DDI-PubMed.18447664.s9.e0" text="Cefdinir" /></sentence><sentence text=" Three weeks later, he again received cefdinir for recurrent otitis media"><entity charOffset="38-46" id="DDI-PubMed.18447664.s10.e0" text="cefdinir" /></sentence><sentence text=" Red stools reappeared 48 hours later, were determined to be guaiac negative, and resolved within hours of drug discontinuation" /><sentence text=" During both occurrences of red stools, the infant had been breastfed and was receiving supplemental feedings with an iron-containing infant formula"><entity charOffset="118-122" id="DDI-PubMed.18447664.s12.e0" text="iron" /></sentence><sentence text=" In the product labeling of cefdinir, this adverse event is described as a consequence of the drug-drug interaction; however, it is not listed in the adverse drug reaction section of the labeling"><entity charOffset="28-36" id="DDI-PubMed.18447664.s13.e0" text="cefdinir" /></sentence><sentence text=" As such, one may miss the association between cefdinir and reddish stools when investigating this event as a potential adverse reaction to cefdinir"><entity charOffset="47-55" id="DDI-PubMed.18447664.s14.e0" text="cefdinir" /><entity charOffset="140-148" id="DDI-PubMed.18447664.s14.e1" text="cefdinir" /><pair ddi="false" e1="DDI-PubMed.18447664.s14.e0" e2="DDI-PubMed.18447664.s14.e0" /><pair ddi="true" e1="DDI-PubMed.18447664.s14.e0" e2="DDI-PubMed.18447664.s14.e1" /></sentence><sentence text=" When using the Naranjo adverse drug reaction probability scale to assess causality in our patient's case, this adverse drug reaction was determined as highly probable" /><sentence text=" As this infant had been breastfed, the use of a supplemental iron-containing infant formula was not identified as a potential contributing factor until the second occurrence of red stools"><entity charOffset="62-66" id="DDI-PubMed.18447664.s16.e0" text="iron" /></sentence><sentence text=" Health care professionals should review the entire product labeling, including the drug-drug interaction section, when investigating a potential adverse drug reaction" /><sentence text=" With the recent approval of generic formulations of cefdinir, clinicians should be aware of this drug-drug interaction with iron-containing products to prevent unnecessary alarm by parents and caregivers, as well as costly medical evaluations for gastrointestinal bleeding"><entity charOffset="53-61" id="DDI-PubMed.18447664.s18.e0" text="cefdinir" /><entity charOffset="125-129" id="DDI-PubMed.18447664.s18.e1" text="iron" /><pair ddi="false" e1="DDI-PubMed.18447664.s18.e0" e2="DDI-PubMed.18447664.s18.e0" /><pair ddi="false" e1="DDI-PubMed.18447664.s18.e0" e2="DDI-PubMed.18447664.s18.e1" /></sentence><sentence text="" /></document>